343 related articles for article (PubMed ID: 35023031)
1. Role of CD44 isoforms in epithelial-mesenchymal plasticity and metastasis.
Primeaux M; Gowrikumar S; Dhawan P
Clin Exp Metastasis; 2022 Jun; 39(3):391-406. PubMed ID: 35023031
[TBL] [Abstract][Full Text] [Related]
2. CD44 staining of cancer stem-like cells is influenced by down-regulation of CD44 variant isoforms and up-regulation of the standard CD44 isoform in the population of cells that have undergone epithelial-to-mesenchymal transition.
Biddle A; Gammon L; Fazil B; Mackenzie IC
PLoS One; 2013; 8(2):e57314. PubMed ID: 23437366
[TBL] [Abstract][Full Text] [Related]
3. TGF-β1 promotes epithelial-to-mesenchymal transition and stemness of prostate cancer cells by inducing PCBP1 degradation and alternative splicing of CD44.
Chen Q; Gu M; Cai ZK; Zhao H; Sun SC; Liu C; Zhan M; Chen YB; Wang Z
Cell Mol Life Sci; 2021 Feb; 78(3):949-962. PubMed ID: 32440711
[TBL] [Abstract][Full Text] [Related]
4. Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.
Roy Burman D; Das S; Das C; Bhattacharya R
Mol Biol Rep; 2021 Jan; 48(1):897-914. PubMed ID: 33400075
[TBL] [Abstract][Full Text] [Related]
5. CD44: A Multifunctional Mediator of Cancer Progression.
Hassn Mesrati M; Syafruddin SE; Mohtar MA; Syahir A
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944493
[TBL] [Abstract][Full Text] [Related]
6. Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial-Mesenchymal Transition, and Metastasis.
Dzobo K; Sinkala M
OMICS; 2021 May; 25(5):313-332. PubMed ID: 33961518
[TBL] [Abstract][Full Text] [Related]
7. Metastatic ability and the epithelial-mesenchymal transition in induced cancer stem-like hepatoma cells.
Nishiyama M; Tsunedomi R; Yoshimura K; Hashimoto N; Matsukuma S; Ogihara H; Kanekiyo S; Iida M; Sakamoto K; Suzuki N; Takeda S; Yamamoto S; Yoshino S; Ueno T; Hamamoto Y; Hazama S; Nagano H
Cancer Sci; 2018 Apr; 109(4):1101-1109. PubMed ID: 29417690
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells.
Bhattacharya R; Mitra T; Ray Chaudhuri S; Roy SS
J Cell Biochem; 2018 Apr; 119(4):3373-3383. PubMed ID: 29130517
[TBL] [Abstract][Full Text] [Related]
9. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
10. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
12. Regulation of alternative splicing of CD44 in cancer.
Prochazka L; Tesarik R; Turanek J
Cell Signal; 2014 Oct; 26(10):2234-9. PubMed ID: 25025570
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis.
Lu W; Kang Y
Dev Cell; 2019 May; 49(3):361-374. PubMed ID: 31063755
[TBL] [Abstract][Full Text] [Related]
14. Direct Regulation of Alternative Splicing by SMAD3 through PCBP1 Is Essential to the Tumor-Promoting Role of TGF-β.
Tripathi V; Sixt KM; Gao S; Xu X; Huang J; Weigert R; Zhou M; Zhang YE
Mol Cell; 2016 Nov; 64(3):549-564. PubMed ID: 27746021
[TBL] [Abstract][Full Text] [Related]
15. CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression.
Brown RL; Reinke LM; Damerow MS; Perez D; Chodosh LA; Yang J; Cheng C
J Clin Invest; 2011 Mar; 121(3):1064-74. PubMed ID: 21393860
[TBL] [Abstract][Full Text] [Related]
16. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L; Losi L; Leyvraz S; Benhattar J
PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
[TBL] [Abstract][Full Text] [Related]
17. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
Garg M
Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
[TBL] [Abstract][Full Text] [Related]
18. Tropomyosin1 isoforms underlie epithelial to mesenchymal plasticity, metastatic dissemination, and resistance to chemotherapy in high-grade serous ovarian cancer.
Xu T; Verhagen MP; Teeuwssen M; Sun W; Joosten R; Sacchetti A; Ewing-Graham PC; Jansen MPHM; Boere IA; Bryce NS; Zeng J; Treutlein HR; Hook J; Hardeman EC; Gunning PW; Fodde R
Cell Death Differ; 2024 Mar; 31(3):360-377. PubMed ID: 38365970
[TBL] [Abstract][Full Text] [Related]
19. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
Liao TT; Yang MH
Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
[TBL] [Abstract][Full Text] [Related]
20. Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.
Zhang FL; Cao JL; Xie HY; Sun R; Yang LF; Shao ZM; Li DQ
Cancer Res; 2018 Oct; 78(20):5780-5792. PubMed ID: 30093560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
